FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:1076-1082 September 11, 2003 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Presentation of Case

A 51-year-old, premenopausal woman came to this hospital with a newly diagnosed breast carcinoma and a strong family history of breast cancer.

Three months earlier, on physical examination at another institution, a mass in the upper outer quadrant of the right breast had been found. Examination of a fine-needle aspirate showed atypical ductal cells. An excisional biopsy, also performed elsewhere, revealed a 0.2-cm invasive lobular carcinoma (stage T1a), with ductal carcinoma in situ and lobular carcinoma in situ (Figure 1).

View larger version (109K): [in this window] [in a new window]   Figure 1. Biopsy Specimen of the Right Breast (Hematoxylin and Eosin). There is a 0.2-cm invasive carcinoma (Panel A, x. . . [Full Text of this Article]

 
Pathological Discussion

Management Discussion

Pathological Diagnosis

Source Information

From the Gillette Center for Women's Cancer (P.D.R., B.L.S.), the Division of Medical Oncology (P.D.R.), the Center for Cancer Risk Analysis (P.D.R., D.A.H., K.M.S.), the Cancer Center (D.A.H.), the Division of Surgical Oncology (B.L.S.), and the Department of Pathology (M.J.F.), Massachusetts General Hospital; and the Departments of Medicine (P.D.R., D.A.H.), Surgery (B.L.S.), and Pathology (M.J.F.), Harvard Medical School — all in Boston.

This article has been cited by other articles:

• Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Isaacs, C., DeMarco, T., Hughes Halbert, C., Pennanen, M., Finch, C. (2005). Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients. Cancer Epidemiol. Biomarkers Prev. 14: 1003-1007 [Abstract] [Full Text]